遠視市場-全球及區域分析：依國家及地區-分析與預測（2025-2035年）

遠視是眼睛的屈光不正，俗稱遠視。

進入眼睛的光線聚焦在視網膜後方，而不是直接聚焦在視網膜上，導致近處物體模糊，遠處物體清晰。遠視通常是由眼球過短或角膜曲率不足引起的。遠視可能是先天性的，嚴重程度不一。遠視的症狀包括閱讀困難、眼睛疲勞、頭痛和近距離視力模糊。遠視通常可以透過配戴眼鏡、隱形眼鏡或屈光矯正手術（例如LASIK）來矯正。

遠視市場的主要驅動力之一是人口老化。隨著老齡化，眼睛自然聚焦於近處物體的能力會下降，導致一種與遠視密切相關的疾病——老花眼。隨著全球人口老化，遠視和老花眼的發病率正在上升，從而增加了對視力矯正解決方案的需求。此外，智慧型手機、電腦和平板電腦等數位裝置的使用增加，導致了數位眼疲勞，從而加劇了遠視症狀。這進一步增加了對眼鏡、隱形眼鏡和先進的雷射視力矯正術的需求，從而推動了遠視市場的顯著成長。此外，人們對可用治療方法的認知不斷提高以及眼鏡技術的進步也有助於擴大市場機會。

儘管遠視市場正在成長，但仍有許多挑戰阻礙其發展。主要挑戰之一是高昂的治療費用，尤其是雷射眼科手術（例如LASIK和 PRK）和高階隱形眼鏡等先進解決方案。雖然這些治療方案能夠帶來長期益處，但前期成本對許多患者來說可能是一個障礙，尤其是在新興市場和缺乏全面醫療保險的個人。此外，缺乏對現有治療方法和定期眼科檢查需求的了解往往會導致診斷延誤，從而引發併發症並加重遠視。另一個挑戰是患者由於擔心安全性、潛在副作用或手術風險而不願接受手術介入。最後，雖然眼鏡和隱形眼鏡是常見的解決方案，但它們並非永久性解決方案，許多患者需要持續維護和頻繁更換，這可能會造成長期沉重的負擔。

全球遠視市場競爭激烈，幾個主要企業推動創新和市場成長。依視路、艾伯維 (Allergan)、博士倫、愛爾康、庫博、Orasis Pharmaceuticals 和再生元製藥等公司處於提供尖端遠視治療和視力矯正解決方案的前沿。依視路憑藉廣泛的眼鏡和鏡片產品組合佔據市場主導地位，提供專為遠視客製化的高清和漸進鏡片。艾伯維 (Allergan) 推出了 Vuity，一種治療老花眼（一種與遠視相關的疾病）的新型藥物。博士倫透過博士倫提供隱形眼鏡和雷射手術技術，而愛爾康則專注於先進的LASIK和隱形眼鏡。庫博公司旗下的 CooperVision 品牌專營隱形眼鏡，並提供高品質的遠視解決方案。 Orasis Pharmaceuticals 正在開發 CSF-1 等前景光明的藥物療法，用於非手術治療老花眼和遠視。 Regeneron Pharmaceuticals 以其眼科疾病研究而聞名，同時也致力於影響更廣泛的眼科護理市場。這些公司在開發創新產品和治療方法處於行業領先地位，提供多種有效治療遠視的選擇，並滿足日益成長的視力矯正解決方案需求。

市場區隔:

細分一：按地區

• 北美洲
• 歐洲
• 亞太地區

全球遠視市場正經歷重大變革時期，其驅動力源自於重塑遠視管理和治療方法的新興趨勢。推動這項轉型的關鍵因素包括LASIK和PRK等雷射手術技術的進步，這些技術正變得更加精準、創傷更小、應用範圍更廣。這些創新使得遠視手術治療更方便有效，恢復時間更短，成功率更高。

此外，為了滿足不斷變化的個人需求，尤其是應對長時間使用螢幕導致的數位眼睛疲勞，智慧眼鏡產品和自我調整鏡片的日益普及也推動了市場需求的轉變。各公司也專注於個人化視力矯正解決方案，提供客製化隱形眼鏡和高清眼鏡，為遠視患者提供舒適和精準的配鏡體驗。老花眼（一種常與遠視相關的疾病）眼藥水等藥物治療的興起，透過提供非手術視力矯正選擇，進一步推動了市場成長。人們日益增強的眼部健康意識，以及防藍光鏡片和多焦點隱形眼鏡等經濟實惠的解決方案的興起，也促進了市場的擴張。總的來說，這些趨勢正在改變遠視市場，使治療更有效、更便捷，並為更廣泛的消費者提供個人化服務。

本報告研究了全球遠視市場，並提供了市場概述以及特定國家和地區的趨勢和公司概況。

目錄

執行摘要

第1章 全球遠視市場：產業展望

• 介紹
• 市場趨勢
• 法律規範
• 流行病學分析
• 臨床試驗分析
• 市場動態

第 2 章。 2023 年至 2035 年全球遠視市場（按地區）

• 北美洲
• 歐洲

第3章全球遠視市場：競爭格局與公司概況

• 關鍵策略和發展
  • 合併與收購
  • 協同活動
  • 業務擴展和資金籌措
  • 產品發布和核准
  • 其他活動
• 公司簡介
  • Essilor Luxottica
  • AbbVie Inc. (Allergan)
  • Bausch Health Companies Inc.
  • Alcon Inc.
  • The Cooper Companies Inc.
  • Orasis Pharmaceuticals
  • Regeneron Pharmaceuticals

第4章調查方法

Global Hyperopia Market, Analysis and Forecast: 2025-2035

Hyperopia is a refractive error in the eye, commonly known as farsightedness. It occurs when light entering the eye is focused behind the retina rather than directly on it, making nearby objects appear blurred while distant objects are seen more clearly. Hyperopia is often caused by the eye being too short or the cornea having insufficient curvature. The condition can be present from birth, and its severity can vary. Symptoms of hyperopia may include difficulty reading, eye strain, headaches, and blurred vision for close-up tasks. It is typically corrected with glasses, contact lenses, or refractive surgeries like LASIK to help focus light properly onto the retina.

One of the key drivers of the Hyperopia market is the aging population. As people age, the natural ability of the eye to focus on close objects diminishes, a condition known as presbyopia, which is closely related to hyperopia. With the global population aging, the incidence of hyperopia and presbyopia is increasing, leading to a higher demand for vision correction solutions. Additionally, the growing use of digital devices like smartphones, computers, and tablets is contributing to digital eye strain, which exacerbates the symptoms of hyperopia. This has further fueled the demand for glasses, contact lenses, and advanced laser vision correction procedures, driving significant growth in the hyperopia market. The increasing awareness of available treatments and advancements in eyewear technology also play a role in expanding market opportunities.

Despite the growth of the Hyperopia market, several challenges continue to hinder its progress. One of the primary challenges is the high cost of treatments, particularly for advanced solutions like laser eye surgeries (such as LASIK or PRK) and premium contact lenses. While these treatments can offer long-term benefits, the initial cost can be a barrier for many patients, especially in emerging markets or for individuals without comprehensive health insurance coverage. Additionally, the lack of awareness about available treatments and the need for regular eye exams often results in delayed diagnosis, which can lead to complications or worsening of hyperopia. Another challenge is the patient resistance to surgical interventions due to concerns about safety, potential side effects, or the perceived risks of surgery. Lastly, while eyeglasses and contact lenses are common solutions, they do not provide a permanent fix, and many individuals require ongoing maintenance or frequent replacements, which can be a significant burden over time.

The global Hyperopia market is highly competitive, with several leading companies driving innovation and market growth. Companies such as Essilor Luxottica, AbbVie Inc. (Allergan), Bausch Health Companies Inc., Alcon Inc., The Cooper Companies Inc., Orasis Pharmaceuticals, and Regeneron Pharmaceuticals are at the forefront of providing cutting-edge solutions for hyperopia treatment and vision correction. Essilor Luxottica dominates the market with its extensive portfolio of eyewear and lenses, offering high-definition lenses and progressive lenses tailored for hyperopia. AbbVie (Allergan) has introduced Vuity, a novel pharmacologic treatment for presbyopia, a condition related to hyperopia. Bausch Health, through its Bausch + Lomb division, provides both contact lenses and laser surgery technologies, while Alcon focuses on advanced LASIK and contact lenses. The Cooper Companies Inc., with its CooperVision brand, specializes in contact lenses, offering high-quality solutions for hyperopia. Orasis Pharmaceuticals is developing promising pharmaceutical treatments like CSF-1 to treat presbyopia and hyperopia non-surgically. Regeneron Pharmaceuticals, although known for its work in ocular diseases, is also positioned to influence the broader eye care market. These companies are leading the way in developing innovative products and therapies, offering a wide range of options to effectively treat hyperopia and meet the growing demand for vision correction solutions.

Market Segmentation:

Segmentation 1: by Region

• North America
• Europe
• Asia-Pacific

The global Hyperopia market is undergoing significant transformation, fueled by emerging trends that are reshaping the way hyperopia is managed and treated. Key drivers of this transformation include advancements in laser surgery technologies like LASIK and PRK, which are becoming more precise, less invasive, and more widely available. These innovations are making surgical treatments for hyperopia more accessible and effective, with quicker recovery times and higher success rates.

Additionally, the increasing adoption of smart eyewear and adaptive lenses that cater to the changing needs of individuals, especially in the context of digital eye strain caused by prolonged screen time, is contributing to a shift in market demand. Companies are also focusing on personalized vision correction solutions, offering customized contact lenses and high-definition eyeglasses that provide greater comfort and precision for individuals with hyperopia. The rise in pharmaceutical treatments, such as eye drops for presbyopia (a condition often linked to hyperopia), is further driving market growth by providing non-surgical alternatives for vision correction. The growing awareness of eye health and the increasing availability of affordable solutions, including blue light-blocking lenses and multifocal contact lenses, are also contributing to the expanding market. These trends are collectively transforming the hyperopia market, making treatments more effective, accessible, and personalized for a wider range of consumers.

Table of Contents

Executive Summary

Scope and Definition

Market/Product Definition

Inclusion and Exclusion

Key Questions Answered

Analysis and Forecast Note

1. Global Hyperopia Market: Industry Outlook

• 1.1 Introduction
• 1.2 Market Trends
• 1.3 Regulatory Framework
• 1.4 Epidemiology Analysis
• 1.5 Clinical Trial Analysis
• 1.6 Market Dynamics
  • 1.6.1 Impact Analysis
  • 1.6.2 Market Drivers
  • 1.6.3 Market Challenges
  • 1.6.4 Market Opportunities

2. Global Hyperopia Market (Region), ($Billion), 2023-2035

• 2.1 North America
  • 2.1.1 Key Findings
  • 2.1.2 Market Dynamics
  • 2.1.3 Market Sizing and Forecast
    • 2.1.3.1 North America Hyperopia Market, by Country
      • 2.1.3.1.1 U.S.
• 2.2 Europe
  • 2.2.1 Key Findings
  • 2.2.2 Market Dynamics
  • 2.2.3 Market Sizing and Forecast
    • 2.2.3.1 Europe Hyperopia Market, by Country
      • 2.2.3.1.1 Germany
      • 2.2.3.1.2 U.K.
      • 2.2.3.1.3 France
      • 2.2.3.1.4 Italy
• 2.3 Asia Pacific
  • 2.3.1 Key Findings
  • 2.3.2 Market Dynamics
  • 2.3.3 Market Sizing and Forecast
    • 2.3.3.1 Asia Pacific Hyperopia Market, by Country
      • 2.3.3.1.1 China
      • 2.3.3.1.2 Japan

3. Global Hyperopia Market: Competitive Landscape and Company Profiles

• 3.1 Key Strategies and Development
  • 3.1.1 Mergers and Acquisitions
  • 3.1.2 Synergistic Activities
  • 3.1.3 Business Expansions and Funding
  • 3.1.4 Product Launches and Approvals
  • 3.1.5 Other Activities
• 3.2 Company Profiles
  • 3.2.1 Essilor Luxottica
    • 3.2.1.1 Overview
    • 3.2.1.2 Top Products / Product Portfolio
    • 3.2.1.3 Top Competitors
    • 3.2.1.4 Target Customers/End-Users
    • 3.2.1.5 Key Personnel
    • 3.2.1.6 Analyst View
  • 3.2.2 AbbVie Inc. (Allergan)
    • 3.2.2.1 Overview
    • 3.2.2.2 Top Products / Product Portfolio
    • 3.2.2.3 Top Competitors
    • 3.2.2.4 Target Customers/End-Users
    • 3.2.2.5 Key Personnel
    • 3.2.2.6 Analyst View
  • 3.2.3 Bausch Health Companies Inc.
    • 3.2.3.1 Overview
    • 3.2.3.2 Top Products / Product Portfolio
    • 3.2.3.3 Top Competitors
    • 3.2.3.4 Target Customers/End-Users
    • 3.2.3.5 Key Personnel
    • 3.2.3.6 Analyst View
  • 3.2.4 Alcon Inc.
    • 3.2.4.1 Overview
    • 3.2.4.2 Top Products / Product Portfolio
    • 3.2.4.3 Top Competitors
    • 3.2.4.4 Target Customers/End-Users
    • 3.2.4.5 Key Personnel
    • 3.2.4.6 Analyst View
  • 3.2.5 The Cooper Companies Inc.
    • 3.2.5.1 Overview
    • 3.2.5.2 Top Products / Product Portfolio
    • 3.2.5.3 Top Competitors
    • 3.2.5.4 Target Customers/End-Users
    • 3.2.5.5 Key Personnel
    • 3.2.5.6 Analyst View
  • 3.2.6 Orasis Pharmaceuticals
    • 3.2.6.1 Overview
    • 3.2.6.2 Top Products / Product Portfolio
    • 3.2.6.3 Top Competitors
    • 3.2.6.4 Target Customers/End-Users
    • 3.2.6.5 Key Personnel
  • 3.2.7 Regeneron Pharmaceuticals
    • 3.2.7.1 Overview
    • 3.2.7.2 Top Products / Product Portfolio
    • 3.2.7.3 Top Competitors
    • 3.2.7.4 Target Customers/End-Users
    • 3.2.7.5 Key Personnel
    • 3.2.7.6 Analyst View

4. Research Methodology

List of Figures

• Figure: Global Hyperopia Market (by Region), $Billion, 2024 and 2035
• Figure: Global Hyperopia Market Key Trends, Analysis

List of Tables

• Table: Global Hyperopia Market Dynamics, Impact Analysis
• Table: Global Hyperopia Market (by Region), $Billion, 2024-2035